NCT00605137View on ClinicalTrials.gov

Safety of Insulin Detemir in Children With Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

83

Participants

Timeline

Start Date

May 21, 2004

Primary Completion Date

April 23, 2005

Study Completion Date

April 23, 2005

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

insulin detemir

DRUG

insulin NPH

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY